The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis
Open accessAbstract
Rheumatoid arthritis (RA) is a systemic poly-articular chronic autoimmune joint disease that mainly damages the hands and feet, which affects 0.5% to 1.0% of the population worldwide. With the sustained development of disease-modifying antirheumatic drugs (DMARDs), significant success has been achieved for preventing and relieving disease activity in RA patients. Unfortunately, some patients still show limited response to DMARDs, which puts forward new requirements for special targets and novel therapies. Understanding the pathogenetic roles of the various molecules in RA could facilitate discovery of potential therapeutic targets and approaches. In this review, both existing and emerging targets, including the proteins, small molecular metabolites, and epigenetic regulators related to RA, are discussed, with a focus on the mechanisms that result in inflammation and the development of new drugs for blocking the various modulators in RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Items 201–250 of 250
Lee, H., Yoo, S., Kim, J., Yoo, I. S., Park, C. K., & Kang, S. W. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02204-0 · Cited by 36
Yang, S., Yin, W., Ding, Y. P., et al. (2020) · Bioscience Reports · doi:10.1042/bsr20201273 · Cited by 36
The Acetyl Code in Rheumatoid Arthritis and Other Rheumatic Diseases
Angiolilli, C., Baeten, D., Radstake, T. R. D. J., & Reedquist, K. A. (2017) · Epigenomics · doi:10.2217/epi-2016-0136 · Cited by 34
Wang, X., Gong, S., Pu, D., Hu, N., Wang, Y., Fan, P., Zhang, J., & Lü, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106067 · Cited by 34
Lee, W. S., Yasuda, S., Kono, M., Kudo, Y., Shimamura, S., Kono, M., Fujieda, Y., Kato, M., Oku, K., Shimizu, T., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108348 · Cited by 34
Chemokines: Their role in rheumatoid arthritis
Vergunst, C. E., & Tak, P. P. (2005) · Current Rheumatology Reports · doi:10.1007/s11926-005-0026-7 · Cited by 33
Zheng, J., Zeng, P., Zhang, H., Zhou, Y., Liao, J., Zhu, W., Jia, N., & Lin, L. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107061 · Cited by 33
Dakin, S. G., Colas, R. A., Wheway, K., Watkins, B., Appleton, L., Rees, J. L., Gwilym, S. E., Little, C., Dalli, J., & Carr, A. J. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.07.011 · Cited by 32
MiR-21 relieves rheumatoid arthritis in rats via targeting Wnt signaling pathway.
Xg, L., Zhang, Y., Wf, J., Li, C., & Yc, M. (2019) · PubMed · doi:10.26355/eurrev_201908_18635 · Cited by 32
Fu, X., Song, G., Ni, R., Liu, H., Xu, Z., Zhang, D., He, F., & Huang, G. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa395 · Cited by 31
Self-citationNtougkos, E., Chouvardas, P., Roumelioti, F., Ospelt, C., Frank‐Bertoncelj, M., Filer, A. D., Buckley, C. D., Gay, S., Nikolaou, C., & Kollias, G. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40128 · Cited by 30
Tian, Y., Terkawi, M. A., Onodera, T., Alhasan, H., Matsumae, G., Takahashi, D., Hamasaki, M., Ebata, T., Aly, M. K., Kida, H., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01720 · Cited by 30
MiR-34a-5p inhibits fibroblast‑like synoviocytes proliferation via XBP1.
Song, A.-F., Kang, L., Wang, Y.-F., & Wang, M. (2020) · PubMed · doi:10.26355/eurrev_202011_23812 · Cited by 30
Ying-ying, G. U. O., Wang, N., Shuai, Z. H. A. O., Hou, L., Xu, Y., & Zhang, N. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20113093 · Cited by 29
Takatani, Y., Ono, K., Suzuki, H., Inaba, M., Sawada, M., & Matsuda, N. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0021-z · Cited by 29
Wang, K.-C., Liu, Y., El‐Shazly, M., Shih, S., Du, Y.-C., Hsu, Y., Lin, H., Chen, Y., Wu, Y., Yang, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081935 · Cited by 28
Jiang, L., & Cao, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29013 · Cited by 28
Role of RP11-83J16.1, a novel long non-coding RNA, in rheumatoid arthritis.
Piao, X., Zhou, J., & Hu, J. (2020) · American Journal of Translational Research · Cited by 27
MiR-145-5p mitigates dysregulated Wnt1/β-catenin signaling pathway in rheumatoid arthritis
Dinesh, P., Kalaiselvan, S., Sujitha, S., & Rasool, M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106328 · Cited by 26
Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing.
Lenert, A., & Fardo, D. W. (2017) · PubMed · Cited by 25
Li, Z., Li, Y., Li, Q., Zhang, Z., Jiang, L., & Li, X. (2018) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-018-0310-2 · Cited by 25
Self-citationThe abnormal expression of CCR4 and CCR6 on Tregs in rheumatoid arthritis.
Li, N., Wei, W., Yin, F., Chen, M., Tian, R., Wu, Q., Zhou, J. R., Zheng, S. G., & Han, J. (2015) · PubMed · Cited by 24
Ahmad, S. F., Akoum, A., & Horne, A. W. (2015) · Molecular Human Reproduction · doi:10.1093/molehr/gav056 · Cited by 24
Yang, Q., Yang, K., & Li, Z. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12124 · Cited by 24
Self-citationZhang, Y., Yan, N., Wang, X., Chang, Y., & Wang, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20192009 · Cited by 24
Jiang, H., Liu, J., Chang, F., Wang, J., & Li, W. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4850 · Cited by 24
CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis
Yamaguchi, A., Nozawa, K., Fujishiro, M., Kawasaki, M., Suzuki, F., Takamori, K., Ogawa, H., Takasaki, Y., & Sekigawa, I. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0752-4 · Cited by 23
Liu, Y., Wei, W., Hong, C., Wang, Y., Sun, X., Ma, J., & Zheng, F. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.01.005 · Cited by 23
Boff, D., Crijns, H., Janssens, R., Vanheule, V., Menezes, G. B., Macari, S., Silva, T. A., Amaral, F. A., & Proost, P. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma1217-502r · Cited by 22
Jordan, L. A., Erlandsson, M. C., Fenner, B. F., Davies, R., Harvey, A. K., Choy, E., Errington, R. J., Bokarewa, M. I., & Williams, A. S. (2018) · Rheumatology · doi:10.1093/rheumatology/key196 · Cited by 22
Ren, B.-D., Liu, J., Wu, K., Zhang, J., Lv, Y., Wang, S., Liu, L., & Liu, D. (2019) · APOPTOSIS · doi:10.1007/s10495-019-01567-3 · Cited by 22
Yu, Z., Liu, H., Fan, J., Chen, F., & Liu, W. (2020) · Mediators of Inflammation · doi:10.1155/2020/4092762 · Cited by 22
Wei, H., Wu, Q., Shi, Y., Luo, A., Lin, S., Feng, X., Jiang, J., Zhang, M., Wang, F., & Tan, W. (2020) · Aging · doi:10.18632/aging.103480 · Cited by 21
Wang, L., Zhao, Q., Wang, N., Ding, Y., Kong, L., & Wang, J. (2021) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-020-00131-4 · Cited by 21
Yang, G., Zhang, C., Wang, N., Yu, M., & Wang, Y. (2018) · Cytokine · doi:10.1016/j.cyto.2018.09.008 · Cited by 20
Xie, Z., Shen, P., Qu, Y., Xu, J., Zheng, C. R., Gao, Y., & Wang, B. (2020) · Environmental Toxicology · doi:10.1002/tox.22923 · Cited by 19
Lin, K., Su, H.-Y., Jiang, L.-F., Chu, T.-G., Li, Z., Chen, X.-L., & Gao, W. (2019) · PubMed · doi:10.26355/eurrev_201903_17228 · Cited by 19
Self-citationTaha, M., Shaker, O. G., Abdelsalam, E., & Taha, N. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00199-7 · Cited by 19
Oelzner, P., Franke, S., Lehmann, G., Eidner, T., Hein, G. E., & Wolf, G. (2010) · Rheumatology International · doi:10.1007/s00296-010-1606-z · Cited by 18
Kim, B.-J., Lee, J.-H., Jin, W. J., Kim, H., Ha, H., & Lee, Z. H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.037 · Cited by 18
Fu, D., Xiao, C., Xie, Y., Gao, J., & Ye, S. (2018) · Gene · doi:10.1016/j.gene.2018.11.014 · Cited by 18
Dey, S., & Bishayi, B. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.02.031 · Cited by 14
LncRNA PlncRNA-1 participates in rheumatoid arthritis by regulating transforming growth factor β1
Wang, Y., Li, G., Guo, W., Ji, B., Aisikeerbayi, A., Boratibai, Y., & Cao, L. (2020) · Autoimmunity · doi:10.1080/08916934.2020.1750010 · Cited by 14
Li, M., Wang, N., Shen, Z., & Yan, J. (2020) · PubMed · Cited by 13
Venugopal, N., Acharya, P., Zarei, M., & Talahalli, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00618-0 · Cited by 12
Wan, L., Liu, J., Huang, C., Жао, Л., Jiang, H., Liu, L., Sun, Y., Xin, L., & Li, Z. (2020) · PubMed · Cited by 11
Self-citationSui, X., Liu, H., & Zhou, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9124 · Cited by 11
Li, Z., Chen, H., Wang, F., Wang, Z., Zhao, Q., Liu, S., Huang, B., Lou, S., & Zuo, J. (2019) · Gene · doi:10.1016/j.gene.2019.05.019 · Cited by 10
Self-citationInterferon‐γ facilitated adjuvant‐induced arthritis at early stage
Ma, H., Xu, M., Song, Y., Zhang, T., Yin, H., & Yin, S. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12757 · Cited by 9
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Macrophages in immunoregulation and therapeutics
Chen, S., Saeed, A. F. U. H., Liu, Q., Jiang, Q., Xu, H., Xiao, G. G., Rao, L., & Duo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01452-1 · Cited by 2,229
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Metadata
- Authors
- Huang, J., Fu, X., Chen, X., Li, Z., Huang, Y., & Liang, C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-07-09
- Volume
- 12
- Pages
- 686155-686155
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3181834541
- Cited by
- 340
- References
- 250
- FWCI
- 32.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.